A detailed history of Norden Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Norden Group LLC holds 10,495 shares of BMY stock, worth $564,211. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,495
Previous 13,846 24.2%
Holding current value
$564,211
Previous $751 Million 41.95%
% of portfolio
0.09%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$40.25 - $52.99 $134,877 - $177,569
-3,351 Reduced 24.2%
10,495 $436 Million
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $10.7 Million - $12.1 Million
-222,760 Reduced 94.15%
13,846 $751 Million
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $10.8 Million - $12.3 Million
225,973 Added 2125.2%
236,606 $12.8 Billion
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $37,475 - $44,718
773 Added 7.84%
10,633 $546 Million
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $570,795 - $638,237
9,860 New
9,860 $572 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $114B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.